The microbiome and rheumatoid arthritis - PubMed (original) (raw)
Review
The microbiome and rheumatoid arthritis
Jose U Scher et al. Nat Rev Rheumatol. 2011.
Abstract
Humans are not (and have never been) alone. From the moment we are born, millions of micro-organisms populate our bodies and coexist with us rather peacefully for the rest of our lives. This microbiome represents the totality of micro-organisms (and their genomes) that we necessarily acquire from the environment. Micro-organisms living in or on us have evolved to extract the energy they require to survive, and in exchange they support the physiological, metabolic and immune capacities that have contributed to our evolutionary success. Although currently categorized as an autoimmune disorder and regarded as a complex genetic disease, the ultimate cause of rheumatoid arthritis (RA) remains elusive. It seems that interplay between predisposing genetic factors and environmental triggers is required for disease manifestation. New insights from DNA sequence-based analyses of gut microbial communities and a renewed interest in mucosal immunology suggest that the microbiome represents an important environmental factor that can influence autoimmune disease manifestation. This Review summarizes the historical clues that suggest a possible role for the microbiota in the pathogenesis of RA, and will focus on new technologies that might provide scientific evidence to support this hypothesis.
Figures
Figure 1
Historical, literary, artistic and paleopathological evidence of RA as a New World disease that has ‘spread’ to the rest of the world. Paleopathological evidence of RA exists only in skeletal remains from New World populations and RA was not documented in the Old World until the late 18th century, whereas other rheumatic diseases have been well described in biblical and ancient texts. Although debated, RA is thought to have spread to Europe after the beginning of trading with the Americas. The first medical literary evidence comes from a paper from 1800 by Landré-Beauvais, who reported his findings in “La goutte asthénique primitive”. In 1859, Alfred Garrod coined the term ‘Rheumatoid Arthritis’. Rubens seems to be the first painter to depict what seems to be RA of the hands in the mid 17th century. Paintings such as The three graces and The miracle of St Ignatius, show ulnar deviation, buttoniere deformities and MCP swelling. Epidemiological evidence supports the notion that RA is a disease of the New World. Amerindians and Eskimos have the highest prevalence of RA, followed by white populations. In keeping with this theory, African and Far East populations, being the latest to be in contact with European conquistadors, have a strikingly low prevalence of RA. Abbreviations: MCP, metacarpophalangeal; RA, rheumatoid arthritis. Permission to use image ‘Sir Alfred Baring Garrod. Photograph by Elliot and Fry’ obtained from the Wellcome Library, London ©
Figure 2
Culture-independent genomic analysis of the human microbiome. Culture-independent techniques have advanced our capacity to survey complex microbial communities in human samples. Well-characterized individuals (healthy and diseased) are asked to donate samples for microbiome analyses. Two metagenomic sequencing approaches are utilized. Conserved and variable 16S rRNA genomic regions are amplified and subjected to pyrosequencing. The resulting sequences are then aligned, filtered and compared to publicly available databases of 16S rRNA sequences, enabling taxonomic classification of bacteria present or absent in a given sample. Whole genome shotgun sequencing provides information that enables identification of genes present and allows for subsequent comparison of enzymatic pathways and functions represented among different samples. Enzymatic databases are also available to assist in the identification of protein function, enabling the richness and diversity of functional capacities provided by the microbiome to be assessed. Abbreviations: PCR, polymerase chain reaction; rRNA, ribosomal RNA.
Figure 3
Host–microbiota interactions in health and inflammatory arthritis. a | In healthy individuals, a well balanced host–microbial cross-talk is essential for the maintenance of homeostasis. A thick mucus layer and epithelial cells prevent direct contact with the gut-associated immune cells, which constantly survey the contents of the intestinal lumen and eliminate undesired antigens. Commensal bacteria, such as Bacteroides fragilis, can activate pro-tolerogenic machinery. A specific cell wall component, PSA, is sufficient to induce TREG-cell activation, IL-10 production and TH17-cell repression to avoid uncontrolled inflammation. b | When either genetic or environmental factors alter the balance in the microbiota composition, dysbiosis ensues. Potentially harmful micro-organisms (such as SFB or Lactobacillus) predominate and local expansion of proinflammatory cells (TH17 cells, TH1 cells and others) occurs via different molecules (such as ATP, SAA or CCL5 signaling). These autoreactive T cells migrate to peripheral immune compartments and activate B cells to differentiate into autoantibody-producing plasma cells. These cells and antibodies then migrate to synovial tissue where the inflammatory cascade is amplified through the activation of effector components, including macrophages, fibroblasts, osteoclasts, cytokines and proteinases. If self-perpetuating, this process can lead to arthritis and pannus formation. Abbreviations: ATP, adenosine-5'-triphosphate; CCL5, CC-chemokine ligand 5; IFNγ, interferon γ; IL-17, interleukin-17; PSA, polysaccharide A; SAA, serum amyloid A; SFB, segmented filamentous bacteria; TH1, type 1 T helper cell; TH17, type 17 T helper cell; TREG, regulatory T cell.
Figure 4
Multiple animal models of inflammatory arthritis have demonstrated that the gut microbiota is critical for the development of disease. The use of gnotobiotic experiments, in which animals are kept germ-free until specific microorganisms are introduced, have advanced our understanding of how local changes in the gut flora produce an imbalance in the proinflammatory and anti-inflammatory immune response and ultimately trigger autoimmunity at distal sites. SFB are sufficient to activate lamina propria TH17 cells in the K/BxN model of inflammatory arthritis. These cells migrate to the periphery, produce IL-17 (their signature cytokine) and stimulate plasma cells to produce arthritogenic autoantibodies. However, when kept in germ-free conditions, these animals do not develop arthritis. Lactobacillus is also capable of arthritis-induction in the Il1rn−/− model. Increase in TH17 cell activity and decrease in TREG cell function are key to the development of joint inflammation. Abbreviations: AA, adjuvant arthritis; CIA, collagen-induced arthritis; IL-17, interleukin-17; SFB, segmented filamentous bacteria; TH1, type 1 T helper cell; TH17, type 17 T helper cell; TLR, Toll-like receptor; TREG, regulatory T cell.
Similar articles
- Arthritis susceptibility and the gut microbiome.
Taneja V. Taneja V. FEBS Lett. 2014 Nov 17;588(22):4244-9. doi: 10.1016/j.febslet.2014.05.034. Epub 2014 May 27. FEBS Lett. 2014. PMID: 24873878 Free PMC article. Review. - Microbiome and probiotics: link to arthritis.
Bedaiwi MK, Inman RD. Bedaiwi MK, et al. Curr Opin Rheumatol. 2014 Jul;26(4):410-5. doi: 10.1097/BOR.0000000000000075. Curr Opin Rheumatol. 2014. PMID: 24841227 Review. - Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis.
Wang Q, Xu R. Wang Q, et al. BMC Genomics. 2019 Feb 11;20(1):124. doi: 10.1186/s12864-019-5510-y. BMC Genomics. 2019. PMID: 30744546 Free PMC article. - [The role of the human microbiom in the pathogenesis of rheumatoid arthritis - a literature review].
Krajewska-Włodarczyk M. Krajewska-Włodarczyk M. Wiad Lek. 2017;70(4):798-803. Wiad Lek. 2017. PMID: 29064808 Review. Polish. - Altered gut microbiota in RA: implications for treatment.
Kang Y, Cai Y, Zhang X, Kong X, Su J. Kang Y, et al. Z Rheumatol. 2017 Jun;76(5):451-457. doi: 10.1007/s00393-016-0237-5. Z Rheumatol. 2017. PMID: 27909795 Review. English.
Cited by
- Efficacy of species-specific protein antibiotics in a murine model of acute Pseudomonas aeruginosa lung infection.
McCaughey LC, Ritchie ND, Douce GR, Evans TJ, Walker D. McCaughey LC, et al. Sci Rep. 2016 Jul 22;6:30201. doi: 10.1038/srep30201. Sci Rep. 2016. PMID: 27444885 Free PMC article. - The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions.
Abdollahi-Roodsaz S, Abramson SB, Scher JU. Abdollahi-Roodsaz S, et al. Nat Rev Rheumatol. 2016 Aug;12(8):446-55. doi: 10.1038/nrrheum.2016.68. Epub 2016 Jun 3. Nat Rev Rheumatol. 2016. PMID: 27256713 Review. - The Microbiome of Animals: Implications for Conservation Biology.
Bahrndorff S, Alemu T, Alemneh T, Lund Nielsen J. Bahrndorff S, et al. Int J Genomics. 2016;2016:5304028. doi: 10.1155/2016/5304028. Epub 2016 Apr 18. Int J Genomics. 2016. PMID: 27195280 Free PMC article. Review. - Rheumatoid arthritis and systemic lupus erythematosus: Pathophysiological mechanisms related to innate immune system.
Pabón-Porras MA, Molina-Ríos S, Flórez-Suárez JB, Coral-Alvarado PX, Méndez-Patarroyo P, Quintana-López G. Pabón-Porras MA, et al. SAGE Open Med. 2019 Sep 13;7:2050312119876146. doi: 10.1177/2050312119876146. eCollection 2019. SAGE Open Med. 2019. PMID: 35154753 Free PMC article. Review. - Altered diversity and composition of the gut microbiome in patients with cervical cancer.
Wang Z, Wang Q, Zhao J, Gong L, Zhang Y, Wang X, Yuan Z. Wang Z, et al. AMB Express. 2019 Mar 23;9(1):40. doi: 10.1186/s13568-019-0763-z. AMB Express. 2019. PMID: 30904962 Free PMC article.
References
- Savage DC. Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 1977;31:107–133. - PubMed
- Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host–bacterial mutualism in the human intestine. Science. 2005;307:1915–1920. - PubMed
- Lederberg J. Infectious history. Science. 2000;288:287–293. - PubMed
- Lederberg J, McCray AT. ‘Ome sweet ‘omics—A genealogical treasury of words. Scientist. 2001;15:8–9.
Publication types
MeSH terms
Grants and funding
- RC2 AR058986/AR/NIAMS NIH HHS/United States
- RC2 AR058986-02/AR/NIAMS NIH HHS/United States
- UL1 RR029893/RR/NCRR NIH HHS/United States
- R01 AR054817/AR/NIAMS NIH HHS/United States
- 1 UL1 RR029893/RR/NCRR NIH HHS/United States
- RC2 AR05898/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical